$CNFN
CFN Enterprises Inc.

2015 Q1 Form 10-Q Financial Statement

#000143774915009700 Filed on May 11, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q1
Revenue $5.200M $3.427M
YoY Change 51.72% 58.67%
Cost Of Revenue $1.318M $789.1K
YoY Change 67.0% 67.89%
Gross Profit $3.882M $2.638M
YoY Change 47.15% 56.1%
Gross Profit Margin 74.66% 76.98%
Selling, General & Admin $2.454M $803.2K
YoY Change 205.6% -28.92%
% of Gross Profit 63.23% 30.44%
Research & Development $875.4K $576.8K
YoY Change 51.77% 51.79%
% of Gross Profit 22.55% 21.86%
Depreciation & Amortization $403.0K $257.0K
YoY Change 56.8% 2470.36%
% of Gross Profit 10.38% 9.74%
Operating Expenses $5.464M $3.002M
YoY Change 81.98% 98.83%
Operating Profit -$1.582M -$364.3K
YoY Change 334.21% -302.39%
Interest Expense -$10.00K $0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net -$12.37K -$3.309K
YoY Change 273.71%
Pretax Income -$1.590M -$370.0K
YoY Change 329.73% -305.56%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.594M -$367.6K
YoY Change 333.67% -253.17%
Net Earnings / Revenue -30.66% -10.73%
Basic Earnings Per Share -$0.03 -$0.01
Diluted Earnings Per Share -$0.03 -$0.01
COMMON SHARES
Basic Shares Outstanding 62.83M 58.77M
Diluted Shares Outstanding 62.83M 58.77M

Balance Sheet

Concept 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.490M $1.130M
YoY Change 31.86% 213.89%
Cash & Equivalents $1.489M $1.131M
Short-Term Investments
Other Short-Term Assets $220.0K $80.00K
YoY Change 175.0% 60.0%
Inventory
Prepaid Expenses
Receivables $1.947M $1.410M
Other Receivables $0.00 $0.00
Total Short-Term Assets $3.654M $2.620M
YoY Change 39.47% 109.6%
LONG-TERM ASSETS
Property, Plant & Equipment $1.446M $860.0K
YoY Change 68.18% 855.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $126.8K $110.0K
YoY Change 15.29%
Total Long-Term Assets $1.772M $1.760M
YoY Change 0.67% 935.29%
TOTAL ASSETS
Total Short-Term Assets $3.654M $2.620M
Total Long-Term Assets $1.772M $1.760M
Total Assets $5.426M $4.380M
YoY Change 23.88% 208.45%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.700M $1.500M
YoY Change 13.33% 581.82%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $500.0K
YoY Change 455.56%
Total Short-Term Liabilities $1.776M $2.050M
YoY Change -13.38% 318.37%
LONG-TERM LIABILITIES
Long-Term Debt $3.900M $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.900M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.776M $2.050M
Total Long-Term Liabilities $3.900M $0.00
Total Liabilities $5.676M $2.050M
YoY Change 176.86% 318.37%
SHAREHOLDERS EQUITY
Retained Earnings -$20.60M
YoY Change
Common Stock $62.83K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$249.8K $2.330M
YoY Change
Total Liabilities & Shareholders Equity $5.426M $4.380M
YoY Change 23.88% 208.45%

Cashflow Statement

Concept 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$1.594M -$367.6K
YoY Change 333.67% -253.17%
Depreciation, Depletion And Amortization $403.0K $257.0K
YoY Change 56.8% 2470.36%
Cash From Operating Activities -$422.5K -$597.7K
YoY Change -29.31% -598.04%
INVESTING ACTIVITIES
Capital Expenditures $44.95K $37.88K
YoY Change 18.67% -175.75%
Acquisitions
YoY Change
Other Investing Activities -$180.0K -$150.0K
YoY Change 20.0% -850.0%
Cash From Investing Activities -$222.4K -$191.9K
YoY Change 15.9% 539.57%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.010M 761.9K
YoY Change 32.51% 1804.69%
NET CHANGE
Cash From Operating Activities -422.5K -597.7K
Cash From Investing Activities -222.4K -191.9K
Cash From Financing Activities 1.010M 761.9K
Net Change In Cash 364.7K -27.65K
YoY Change -1419.27% -121.27%
FREE CASH FLOW
Cash From Operating Activities -$422.5K -$597.7K
Capital Expenditures $44.95K $37.88K
Free Cash Flow -$467.4K -$635.5K
YoY Change -26.45% -473.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 aclzob Cashless Exercise Of Options
CashlessExerciseOfOptions
600000
CY2015Q1 aclzob Cashless Exercise Of Options
CashlessExerciseOfOptions
600000
CY2014Q1 aclzob Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
11458
CY2015Q1 aclzob Cashless Exercise Of Warrants
CashlessExerciseOfWarrants
11458
CY2015Q1 aclzob Class Of Warrant Or Right Exercise Of Warrants
ClassOfWarrantOrRightExerciseOfWarrants
11457
CY2014Q1 aclzob Class Of Warrant Or Right Exercise Of Warrants
ClassOfWarrantOrRightExerciseOfWarrants
862500
CY2015Q1 aclzob Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
37289
CY2014Q1 aclzob Fair Value Of Warrants Issued In Connection With Line Of Credit
FairValueOfWarrantsIssuedInConnectionWithLineOfCredit
32067
CY2014Q1 aclzob Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
5233
CY2015Q1 aclzob Stock Issued During Period Shares Warrants Exercised
StockIssuedDuringPeriodSharesWarrantsExercised
5233
CY2015Q1 aclzob Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations
WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations
62831019
CY2014Q1 aclzob Weighted Average Number Of Diluted Shares Outstanding Discontinued Operations
WeightedAverageNumberOfDilutedSharesOutstandingDiscontinuedOperations
58770491
CY2015Q1 aclzob Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss
WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss
19752825
CY2014Q1 aclzob Weightedaverage Antidilutive Securities Excluded From Computation Of Earnings Per Share Amountloss
WeightedaverageAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountloss
24496668
CY2015Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1700489
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1202495
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1946622
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1749566
CY2015Q1 us-gaap Accumulated Amortization Of Noncurrent Deferred Finance Costs
AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts
26867
CY2014Q4 us-gaap Accumulated Amortization Of Noncurrent Deferred Finance Costs
AccumulatedAmortizationOfNoncurrentDeferredFinanceCosts
19317
CY2015Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1063158
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
826802
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-17514
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10971
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
20301678
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1157315
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1488837
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1130870
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
358170
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-26445
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
19618153
CY2015Q1 us-gaap Advertising Expense
AdvertisingExpense
151497
CY2014Q2 us-gaap Advertising Expense
AdvertisingExpense
32211
CY2015Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
15808
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
212113
CY2015Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
7550
CY2014Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
3003
CY2015Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
163854
CY2014Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
58023
CY2015Q1 us-gaap Assets
Assets
5425856
CY2014Q4 us-gaap Assets
Assets
4976393
CY2015Q1 us-gaap Assets Current
AssetsCurrent
3654100
CY2014Q4 us-gaap Assets Current
AssetsCurrent
3084501
CY2015Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
35448
CY2015Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
855294
CY2014Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
604230
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1130667
CY2015Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62833244
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
62816554
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62833244
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
62816554
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
62832
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
62815
CY2015Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1600765
CY2014Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-366284
CY2014Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
296296
CY2015Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Concentration of Credit Risks</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company is subject to concentrations of credit risk primarily from cash and cash equivalents and accounts receivable.</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company&#x2019;s cash and cash equivalents accounts are held at a financial institution and are insured by the Federal Deposit Insurance Corporation, or the FDIC, up to $250,000. During the three-month period ended March 31, 2015, the Company has reached bank balances exceeding the FDIC insurance limit. To reduce its risk associated with the failure of such financial institutions, the Company periodically evaluates the credit quality of the financial institution in which it holds deposits.</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The Company's accounts receivable are due from customers, generally located in the United States, Europe, Asia, and Canada. None of the Company&#x2019;s customers accounted for more than 10% of its accounts receivable at March 31, 2015 or December 31, 2014.&nbsp;&nbsp;The Company does not require any collateral from its customers.</div></div></div></div>
CY2015Q1 us-gaap Cost Of Revenue
CostOfRevenue
1317766
CY2014Q1 us-gaap Cost Of Revenue
CostOfRevenue
789099
CY2015Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
68990
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
37750
CY2015Q1 us-gaap Deferred Revenue
DeferredRevenue
75167
CY2014Q4 us-gaap Deferred Revenue
DeferredRevenue
206475
CY2015Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
75167
CY2014Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
206475
CY2015Q1 us-gaap Depreciation
Depreciation
72502
CY2014Q1 us-gaap Depreciation
Depreciation
32347
CY2015Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
403021
CY2014Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
257036
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-6543
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
1200
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1664000
CY2015Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y
CY2015Q1 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2014Q1 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0
CY2015Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
870369
CY2014Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
703704
CY2015Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
129631
CY2015Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
129631
CY2015Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
129631
CY2015Q1 us-gaap Gross Profit
GrossProfit
3881896
CY2014Q1 us-gaap Gross Profit
GrossProfit
2638098
CY2015Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-1594222
CY2014Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-367614
CY2015Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2014Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
0
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
461045
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-206803
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
751
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
336782
CY2015Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-131308
CY2014Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-25311
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-6174
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
37148
CY2015Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
14373
CY2014Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-8143
CY2015Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
45344
CY2014Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
3309
CY2015Q1 us-gaap Interest Paid
InterestPaid
0
CY2014Q1 us-gaap Interest Paid
InterestPaid
0
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
32978
CY2015Q1 us-gaap Liabilities
Liabilities
5675656
CY2014Q4 us-gaap Liabilities
Liabilities
4308970
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5425856
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4976393
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1775656
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1408970
CY2015Q1 us-gaap Line Of Credit
LineOfCredit
3900000
CY2015Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
6000000
CY2014Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
3000000
CY2015Q1 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
3900000
CY2014Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
2900000
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-222371
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-191871
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-422502
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1009586
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
761876
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-597650
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-1594222
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-367614
CY2015Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1594222
CY2014Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-367614
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12366
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3309
CY2015Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2014Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2015Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
5463752
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
3002403
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-1581856
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-364305
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
126814
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
132988
CY2015Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-6543
CY2014Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1330
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6543
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1330
CY2015Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6543
CY2014Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1330
CY2014Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
40000
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
44947
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
37875
CY2015Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
177424
CY2014Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
153996
CY2015Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
218641
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
204268
CY2015Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
1000000
CY2014Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
500000
CY2015Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
9586
CY2014Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
301876
CY2015Q1 us-gaap Profit Loss
ProfitLoss
-1594222
CY2014Q1 us-gaap Profit Loss
ProfitLoss
-367614
CY2015Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2509479
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2251660
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1446321
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1424858
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19002574
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-20596796
CY2015Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-196305
CY2014Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-35951
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
875382
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
576786
CY2015Q1 us-gaap Revenues
Revenues
5199662
CY2014Q1 us-gaap Revenues
Revenues
3427197
CY2014Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1622449
CY2015Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2454446
CY2014Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
803168
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.40
CY2015Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2133924
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.64
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
10000000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
22500000
CY2011Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
15000000
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
22500000
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
22500
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
907500
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.66
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.73
CY2015Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate
0.009
CY2014Q1 us-gaap Share Based Goods And Nonemployee Services Transaction Valuation Method Risk Free Interest Rate
ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate
0.009
CY2015Q1 us-gaap Share Price
SharePrice
1.40
CY2014Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
CY2014Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
519252
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
519252
CY2015Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
636667
CY2014Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
143777
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
-249800
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
667423
CY2015Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of unaudited condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reporting amounts of revenues and expenses during the reported period. Actual results will differ from those estimates. Included in these estimates are assumptions about collection of accounts receivable, useful life of fixed assets and intangible assets, and assumptions used in Black-Scholes-Merton, or BSM, valuation methods, such as expected volatility, risk-free interest rate, and expected dividend rate.</div></div></div></div>
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
62831019
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58770491
CY2015Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
62831019
CY2014Q1 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
58770491
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
62831019
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58770491

Files In Submission

Name View Source Status
0001437749-15-009700-index-headers.html Edgar Link pending
0001437749-15-009700-index.html Edgar Link pending
0001437749-15-009700.txt Edgar Link pending
0001437749-15-009700-xbrl.zip Edgar Link pending
aclz20150331_10q.htm Edgar Link pending
aclzob-20150331.xml Edgar Link completed
aclzob-20150331.xsd Edgar Link pending
aclzob-20150331_cal.xml Edgar Link unprocessable
aclzob-20150331_def.xml Edgar Link unprocessable
aclzob-20150331_lab.xml Edgar Link unprocessable
aclzob-20150331_pre.xml Edgar Link unprocessable
ex10-1.htm Edgar Link pending
ex10-2.htm Edgar Link pending
ex10-2img001.jpg Edgar Link pending
ex10-2img002.jpg Edgar Link pending
ex10-3.htm Edgar Link pending
ex10-4.htm Edgar Link pending
ex10-5.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-1.htm Edgar Link pending
ex4-1img001.jpg Edgar Link pending
ex4-1img002.jpg Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending